Febuxostat Tablets

Febuxostat Tablets
SPL v3
SPL
SPL Set ID 0629ab39-196e-4198-902a-3c16277ba205
Route
ORAL
Published
Effective Date 2024-08-16
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Febuxostat (40 mg)
Inactive Ingredients
Silicon Dioxide Croscarmellose Sodium Hypromelloses Lactose Monohydrate Cellulose, Microcrystalline Polyethylene Glycol, Unspecified Povidone Sodium Stearyl Fumarate Talc Titanium Dioxide

Identifiers & Packaging

Pill Appearance
Imprint: 402 Shape: oval Shape: round Color: white Size: 13 mm Size: 12 mm Score: 1
Marketing Status
ANDA Active Since 2023-03-31

Description

Febuxostat Tablets, 40 mg – 30's count NDC- 70771-1552-3 Febuxostat Tablets, 80 mg – 30's count NDC- 70771-1553-3


Medication Information

Description

Febuxostat Tablets, 40 mg – 30's count NDC- 70771-1552-3 Febuxostat Tablets, 80 mg – 30's count NDC- 70771-1553-3

Package Label.principal Display Panel

Febuxostat Tablets, 40 mg – 30's count

NDC- 70771-1552-3

Febuxostat Tablets, 80 mg – 30's count

NDC- 70771-1553-3


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

Febuxostat Tablets, 40 mg – 30's count

NDC- 70771-1552-3

Febuxostat Tablets, 80 mg – 30's count

NDC- 70771-1553-3


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)